vendredi 27 juillet 2018

Onco Actu du 27 juillet 2018

3.1 Prévention - Tabac

FDA In Brief: FDA affirms commitment to warning the public about nicotine in tobacco products following court ruling [FDA]

3.8 Prévention - Alimentation

Adherence to Healthy Diets Associated with Lower Cancer Risk [AACR]

4.14 Dép., diag. & prono. - Thyroïde

MicroRNA Panel Can Identify Malignancy in Indeterminate Thyroid Nodules [AACR]

5.1 Traitements - Pré-clinique

Scientists discover a mechanism of drug resistance in breast and ovarian cancer [Rockefeller University]

5.12.5 Immunothérapies - Pharma

Bristol-Myers to get negative CHMP opinion on renal cancer drugs [Reuters]

5.12.6 Immunothérapies - AMM

KEYTRUDA® (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma [Merck]

FDA Alters Approved Use of Two Checkpoint Inhibitors for Bladder Cancer [NCI]

5.12.8 Immunothérapies - Economie

AstraZeneca's new launches shine in Q2 as it inches toward turnaround [FiercePharma]

Bristol-Myers surprise: Threatened I-O drug Opdivo stands its ground in lung cancer [FiercePharma]

5.2 Pharma

AstraZeneca Can't Boost a Cancer Drug Stockpile for Brexit [Bloomberg]

5.2.1 Pharma - Partenariats

23andMe Sold Access to Your DNA Library to Big Pharma, But You Can Opt Out [Motherboard]

5.2.3 Pharma - économie

On top of expiring Herceptin patents, Roche faces huge royalty losses in 2019 [EndPoints]

Sutro Biopharma Announces $85.4 Million Series E Round [Sutro]

Days after Merck deal, Sutro rolls out $85M E round to fund internal cancer pipeline [EndPoints]

5.4 Traitements - Economie

NICE Issues Technology Appraisal Guidance on Crizotinib for Treating ROS1-positive Advanced NSCLC [ESMO]

6.1 Observation

Half of U.S. breast surgeons may advise unneeded lymph node removal [Reuters]

6.6 Publications

A Q&A with John Pham, the new Editor-in-Chief of Cell [CellPress]

Technology + Engagement = Infrastructure Sustainability [ORCID]

6.7 DMP, Big Data & applis

Powerful people in health care are finding a new landing pad: Google [STAT]